Expanding the Spectrum: Modified Bacteriocin Nisin as a Trojan Horse Against Gram‐Negative Salmonella Typhimurium and Escherichia coli
Biotechnology Journal · 2025
DOI: 10.1002/biot.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Lucia Lanza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Superior de Investigaciones Biológicas (INSIBIO, CONICET-UNT) e Instituto de Química Biológica "Dr. Bernabé Bloj", Facultad de Bioquímica, …. Hauptthemen laut MEDLINE: Nisin, Salmonella typhimurium, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Agencia Nacional de Promoción Científica y Tecnológica (Agencia I+D), Secretaría de Ciencia, Arte e Innovación Tecnológica (SCAIT) from Universidad Nacional de Tucumán (UNT).
Abstract (Originalsprache)
Nisin is an antimicrobial peptide widely used as a biopreservative to extend shelf life and control foodborne pathogens, particularly Gram‐positive bacteria such as Listeria monocytogenes . However, its efficacy against Gram‐negative bacteria is limited due to its inability to penetrate their outer membrane and reach its target, lipid II, in the inner membrane. Agents that alter the outer membrane's permeability can overcome this limitation, enabling nisin to access the periplasm and expand its antimicrobial spectrum. In this study, we aimed to extend nisin's spectrum of action towards Gram‐negative bacteria by fusing it with salmochelin, a siderophore produced by Salmonella . Siderophores capture extracellular iron and enter cells through specific receptors. The nisin‐salmochelin conjugate was synthesized through an external chemical reaction, yielding a compound with activity against Gram‐positive and Gram‐negative bacteria. Among the Gram‐negative bacteria, notable strains include Salmonella enterica Newport , S. enterica Typhimurium, Escherichia coli O157, E. coli EC3 (uropathogenic isolate), and Providencia rettgeri . This novel conjugate exhibits broad‐spectrum activity against foodborne pathogens, significantly enhancing nisin's potential as a food biopreservative and expanding its clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Superior de Investigaciones Biológicas (INSIBIO, CONICET-UNT) e Instituto de Química Biológica "Dr. Bernabé Bloj", Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, San Miguel de Tuc…
- Instituto de Química del Noroeste Argentino (INQUINOA, CONICET-UNT), Facultad de Bioquímica y Farmacia, Universidad Nacional de Tucumán, San Miguel de Tucumán, Tucumán, Argentina.
ORCID-Profile: Lucia Lanza, Ruth E Masias, Miriam C Chalón, Mauricio Cattaneo, Augusto Bellomio
Förderung
- Agencia Nacional de Promoción Científica y Tecnológica (Agencia I+D)
- Secretaría de Ciencia, Arte e Innovación Tecnológica (SCAIT) from Universidad Nacional de Tucumán (UNT)
Zitieren
APA
Lanza, L., Masias, R. E., Chalón, M. C., Cattaneo, M., & Bellomio, A. (2025). Expanding the Spectrum: Modified Bacteriocin Nisin as a Trojan Horse Against Gram‐Negative Salmonella Typhimurium and Escherichia coli. Biotechnology Journal. https://doi.org/10.1002/biot.70019
Vancouver
Lanza L, Masias RE, Chalón MC, Cattaneo M, Bellomio A. Expanding the Spectrum: Modified Bacteriocin Nisin as a Trojan Horse Against Gram‐Negative Salmonella Typhimurium and Escherichia coli. Biotechnology Journal. 2025. doi:10.1002/biot.70019
BibTeX
@article{Lanza2025,
author = {Lanza, Lucia and Masias, Ruth E and Chalón, Miriam C and Cattaneo, Mauricio and Bellomio, Augusto},
title = {Expanding the Spectrum: Modified Bacteriocin Nisin as a Trojan Horse Against Gram‐Negative Salmonella Typhimurium and Escherichia coli},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70019}
}
EUVIMED